Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 195-204

  Stoecklin, E ^a   Wissler, M ^a   Schaetzle, D ^a   Pfitzner, E ^a   Groner, B ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN; CYTOKINE RECEPTOR; DNA; STAT5 PROTEIN; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONFERENCE PAPER; CONTROLLED STUDY; DNA BINDING; GENETIC TRANSFECTION; HOMEOSTASIS; MONKEY; NONHUMAN; PLASMID; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CASEINS; COS CELLS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; MILK PROTEINS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0033047771     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00052-7     Document Type: Conference Paper

References (57)

1. Beato M., Herrlich P., Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 83:1995;851-857.
2. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., et al. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
3. Parker M.G. Nuclear hormone receptors: Molecular mechanisms, cellular functions, clinical abnormalities. 1991;397 Academic Press Ltd, London.
4. Giguere V., Hollenberg S.M., Rosenfeld M.G., Evans R.M. Functional domains of the human glucocorticoid receptor. Cell. 46:1986;645-652.
5. Danielsen M. Structure and function of the glucocorticoid receptor. Parker M.G. Nuclear hormone receptors: Molecular mechanisms, cellular functions, clinical abnormalities. 1991;39-78 Academic Press Ltd, London.
6. Kumar V., Green S., Stack G., Berry M., Jin J.R., Chambon P. Functional domains of the human estrogen receptor. Cell. 51:1987;941-951.
7. Martinez E, Wahli W. Characterization of hormone response elements. Parker M.G. Nuclear hormone receptors: Molecular mechanisms, cellular functions, clinical abnormalities. 1991;125-153 Academic Press Ltd, London.
8. Gouilleux F., Wakao H., Mundt M., Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 13:1994;4361-4369.
9. Gouilleux F., Pallard C., Dusanter-Fourt I., Wakao H., Haldosen L.A., Norstedt G., Levy D., Groner B. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 14:1995;2005-2013.
10. Schindler C., Darnell J.E. Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:1995;621-651.
11. Ihle J.N. Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells. Adv. Cancer Res. 68:1996;23-65.
12. Pellegrini S., Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 248:1997;615-633.
13. Moriggl R., Gouilleux-Gruart V., Jahne R., Berchtold S., Gartmann C., Liu X., Hennighausen L., Sotiropoulos A., Groner B., Gouilleux F. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol. 16:1996;5691-5700.
14. Doppler W., Groner B., Ball R.K. Prolactin and glucocorticoid hormones synergistically induce expression of transfected rat beta-casein gene promoter constructs in a mammary epithelial cell line. Proc. Natl Acad. Sci. USA. 86:1989;104-108.
15. Altiok S., Groner B. Interaction of two sequence-specific single-stranded DNA-binding proteins with an essential region of the beta-casein gene promoter is regulated by lactogenic hormones. Mol. Cell. Biol. 13:1993;7303-7310.
16. Cella N., Groner B., Hynes N.E. Glucocorticoid receptor-Stat5a/5b association regulates lactogenic hormone-dependent beta-casein gene expression. Mol. Cell. Biol. 18:1998;1783-1792.
17. Groner B., Gouilleux F. Prolactin-mediated gene activation in mammary epithelial cells. Curr. Opin. Genet. Dev. 5:1995;587-594.
18. Kazansky A.V., Raught B., Lindsey S.M., Wang Y.F., Rosen J.M. Regulation of mammary gland factor/Stat5a during mammary gland development. Mol. Endocrinol. 9:1995;1598-1609.
19. Schmitt-Ney M., Doppler W., Ball R.K., Groner B. Beta-casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland-specific nuclear factor. Mol. Cell. Biol. 11:1991;3745-3755.
20. Wakao H., Gouilleux F., Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response [published erratum appears in EMBO J. 1995 Feb 15;14(4):854-5]. EMBO J. 13:1994;2182-2191.
21. Stoecklin E., Wissler M., Gouilleux F., Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature. 383:1996;726-728.
22. Stoecklin E., Wissler M., Moriggl R., Groner B. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional co-operation in the regulation of gene transcription. Mol. Cell. Biol. 17:1997;6708-6716.
23. Green S., Chambon P. The oestrogen receptor: From perception to mechanism. Parker M.G. Nuclear hormone receptors: Molecular mechanisms, cellular functions, clinical abnormalities. 1991;15-38 Academic Press Ltd, London.
24. Heck S., Kullmann M., Gast A., Ponta H., Rahmsdorf H.J., Herrlich P., Cato A.C. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13:1994;4087-4095.
25. Ali S., Metzger D., Bornert J.M., Chambon P. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12:1993;1153-1160.
26. Kuiper G.G., de Ruiter P.E., Grootegoed J.A., Brinkmann A.O. Synthesis and post-translational modification of the androgen receptor in LNCaP cells. Mol. Cell. Endocrinol. 80:1991;65-73.
27. Becker S., Groner B., Mueller C.W. Three-dimensional structure of the Stat3-beta homodimer bound to DNA. Nature. 394:1998;145-151.
28. Schwabe J.W., Chapman L., Finch J.T., Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell. 75:1993;567-578.
29. Beato M., Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 17:1996;587-609.
30. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 384:1996;641-643.
31. Glass C.K., Rose D.W., Rosenfeld M.G. Nuclear receptor coactivators. Curr. Opin. Cell. Biol. 9:1997;222-232.
32. Orphanides G., Lagrange T., Reinberg D. The general transcription factors of RNA polymerase II. Genes Dev. 10:1996;2657-2683.
33. Jenster G., Spencer T.E., Burcin M.M., Tsai S.Y., Tsai M.J., Bw O.M. Steroid receptor induction of gene transcription: a two-step model. Proc. Natl Acad. Sci. USA. 94:1997;7879-7884.
34. Le Douarin B., Nielsen A.L., Garnier J.M., Ichinose H., Jeanmougin F., Losson R., Chambon P. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 15:1996;6701-6715.
35. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959.
36. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.J., Bw O.M. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 389:1997;194-198.
37. Cavailles V., Dauvois S., Fl H., Lopez G., Hoare S., Kushner P.J., Parker M.G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:1995;3741-3751.
38. Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., Ad A., Livingston D.M. Co-operation of Stat2 and p300/CBP in signalling induced by interferon- alpha. Nature. 383:1996;344-347.
39. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., Evans R.M. Role of CBP/P300 in nuclear receptor signalling [see comments]. Nature. 383:1996;99-103.
40. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 90:1997;569-580.
41. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors [see comments]. Nature. 387:1997;733-736.
42. Horvai A.E., Xu L., Korzus E., Brard G., Kalafus D., Mullen T.M., Rose D.W., Rosenfeld M.G., Glass C.K. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl Acad. Sci. USA. 94:1997;1074-1079.
43. McEwan I.J., Wright A.P., Gustafsson J.A. Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays. 19:1997;153-160.
44. Onate S.A., Tsai S.Y., Tsai M.J., Bw O.M. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
45. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear- receptor function [see comments]. Nature. 387:1997;677-684.
46. Yao T.P., Ku G., Zhou N., Scully R., Livingston D.M. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl Acad. Sci. USA. 93:1996;10626-10631.
47. Zhang J.J., Vinkemeier U., Gu W., Chakravarti D., Horvath C.M., Darnell J.E. Jr. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc. Natl Acad. Sci. USA. 93:1996;15092-15096.
48. Alland L., Muhle R., Hou H. Jr, Potes J., Chin L., Schreiber-Agus N., DePinho R.A. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression [see comments]. Nature. 387:1997;49-55.
49. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors [see comments]. Nature. 377:1995;454-457.
50. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Soderstrom M., Glass C.K., et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor [see comments]. Nature. 377:1995;397-404.
51. Horwitz K.B., Jackson T.A., Bain D.L., Richer J.K., Takimoto G.S., Tung L. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10:1996;1167-1177.
52. Kepa J.K., Jacobsen B.M., Boen E.A., Prendergast P., Edwards D.P., Takimoto G., Wierman M.E. Direct binding of progesterone receptor to nonconsensus DNA sequences represses rat GnRH. Mol. Cell. Endocrinol. 117:1996;27-39.
53. Almlof T., Wright A.P., Gustafsson J.A. Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. J. Biol. Chem. 270:1995;17535-17540.
54. Beadling C., Ng J., Babbage J.W., Cantrell D.A. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 15:1996;1902-1913.
55. Hoeck W., Rusconi S., Groner B. Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially expressed receptor fragment. J. Biol. Chem. 264:1989;14396-14402.
56. Hoeck W., Groner B. Hormone-dependent phosphorylation of the glucocorticoid receptor occurs mainly in the amino-terminal transactivation domain. J. Biol. Chem. 265:1990;5403-5408.
57. Bamberger C.M., Schulte H.M., Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17:1996;245-261.